GEHC Earnings & Financial Statements
GE HealthCare Technologies Inc.
$65.44
+$1.22(+1.89%)
45
Overall
80
Value
10
Tech
47
Quality
Market Cap
$29.01B
Volume
1.23M
52W Range
$58.75 - $89.77
Target Price
$82.39
GEHC earnings and financial statements: GE HealthCare Technologies Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
GEHC Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | $20.63B | $19.67B | $19.55B |
| Cost of revenue | - | $11.47B | $11.63B |
| Operating income | $2.76B | $2.63B | $2.44B |
| EBITDA | $3.79B | $3.67B | $3.51B |
| Net income | $2.08B | $1.99B | $1.57B |
| EPS (diluted) | $4.55 | $4.34 | $3.03 |
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Total assets | $36.91B | $33.09B | $32.45B |
| Total liabilities | $26.31B | $24.44B | $25.14B |
| Shareholders’ equity | $10.38B | $8.45B | $7.13B |
| Cash and equivalents | $4.49B | $2.87B | $2.49B |
| Long-term debt | $9.49B | $7.45B | $8.44B |
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating cash flow | $1.99B | $1.96B | $2.10B |
| Capital expenditure | -$482.00M | -$401.00M | -$387.00M |
| Free cash flow | $1.50B | $1.55B | $1.71B |
| Dividends paid | $64.00M | $55.00M | $41.00M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GEHC | $65.44 | +1.9% | 1.23M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get GE HealthCare Technologies Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW